Back | Next |
home / stock / indp / indp message board
Subject | By | Source | When |
---|---|---|---|
Long and strong lets hope im right | Zardiw | investorshub | 04/18/2023 9:44:26 AM |
Long and strong lets hope im right | MonstaGains | investorshub | 04/17/2023 9:20:34 AM |
where is the squeeze? | TheFinalCD | investorshub | 04/16/2023 8:06:21 AM |
Price gaining up | masterofdisaster | investorshub | 04/15/2023 8:09:27 PM |
$INDP When is this gonna take off? | MonstaGains | investorshub | 04/15/2023 5:47:31 PM |
Have a look at this | KnightTrader66 | investorshub | 04/15/2023 2:46:19 PM |
$INDP short squeeze signal | otterman | investorshub | 04/14/2023 1:34:14 PM |
MomentumIts gaining | MonstaGains | investorshub | 04/09/2023 5:45:44 AM |
Indaptus Therapeutics Announces FDA Clearance of Investigational New | subslover | investorshub | 05/19/2022 1:01:52 PM |
keeping on watch 5.80 | alchemytrader | investorshub | 12/31/2021 1:40:29 PM |
Presentation link. They now own Decoy Bios patents, | KnightTrader66 | investorshub | 12/06/2021 11:11:11 PM |
Lots of good DD here: | KnightTrader66 | investorshub | 12/06/2021 11:10:26 PM |
Where is everyone? | KnightTrader66 | investorshub | 12/06/2021 11:08:11 PM |
Pending a Mega bounce? | Cubanwinner | investorshub | 09/20/2021 10:58:29 PM |
CEO bought $84k worth, not too bad. | Surfacetite | investorshub | 09/17/2021 1:53:10 AM |
This could be another $IRNT | masterofdisaster | investorshub | 09/17/2021 12:56:53 AM |
Today, I believe it will continue to go | SriMaharaj | investorshub | 09/16/2021 3:08:07 PM |
Ya, I'm all out for a nice profit | DeadCellShadix | investorshub | 09/16/2021 1:41:24 PM |
its movin! | Surfacetite | investorshub | 09/16/2021 8:27:18 AM |
It's a simple explanation...The classic formula for Manipulated | Justfactsmam | investorshub | 09/15/2021 10:53:46 PM |
News, Short Squeeze, Breakout and More Instantly...
Indaptus Therapeutics Inc. Company Name:
INDP Stock Symbol:
NASDAQ Market:
Indaptus Therapeutics Inc. Website:
- Chief Scientific Officer Dr. Newman to present initial clinical data that further validates Company’s “Pulse-Prime” hypothesis - Dr. Newman also named Chair of the Summit NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a...
NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc, (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced that its Chief Medical Officer, Roger Waltzman, M.D., will present an update on ...
Latest data from first and second cohorts support Company’s 'pulse-prime' approach, demonstrating rapid clearance, broad immune activation, and encouraging safety profile Poster Presented at American Society of Clinical Oncology Annual Meeting NEW YORK, June 03, 2024 (GLOBE...